Tag: Otsuka Pharmaceutical
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
English
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Paul Chow shares his views on shaping HKEX legal strategy, sustainability leadership and responsible AI use in markets